Cargando…

Biomimetic Nanocarriers for Cancer Target Therapy

Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo’s protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All toget...

Descripción completa

Detalles Bibliográficos
Autores principales: Guido, Clara, Maiorano, Gabriele, Cortese, Barbara, D’Amone, Stefania, Palamà, Ilaria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552783/
https://www.ncbi.nlm.nih.gov/pubmed/32937963
http://dx.doi.org/10.3390/bioengineering7030111
_version_ 1783593477517344768
author Guido, Clara
Maiorano, Gabriele
Cortese, Barbara
D’Amone, Stefania
Palamà, Ilaria Elena
author_facet Guido, Clara
Maiorano, Gabriele
Cortese, Barbara
D’Amone, Stefania
Palamà, Ilaria Elena
author_sort Guido, Clara
collection PubMed
description Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo’s protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suffer low therapeutic efficacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, different modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic efficacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of different cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed.
format Online
Article
Text
id pubmed-7552783
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75527832020-10-19 Biomimetic Nanocarriers for Cancer Target Therapy Guido, Clara Maiorano, Gabriele Cortese, Barbara D’Amone, Stefania Palamà, Ilaria Elena Bioengineering (Basel) Review Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo’s protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suffer low therapeutic efficacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, different modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic efficacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of different cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed. MDPI 2020-09-14 /pmc/articles/PMC7552783/ /pubmed/32937963 http://dx.doi.org/10.3390/bioengineering7030111 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Guido, Clara
Maiorano, Gabriele
Cortese, Barbara
D’Amone, Stefania
Palamà, Ilaria Elena
Biomimetic Nanocarriers for Cancer Target Therapy
title Biomimetic Nanocarriers for Cancer Target Therapy
title_full Biomimetic Nanocarriers for Cancer Target Therapy
title_fullStr Biomimetic Nanocarriers for Cancer Target Therapy
title_full_unstemmed Biomimetic Nanocarriers for Cancer Target Therapy
title_short Biomimetic Nanocarriers for Cancer Target Therapy
title_sort biomimetic nanocarriers for cancer target therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552783/
https://www.ncbi.nlm.nih.gov/pubmed/32937963
http://dx.doi.org/10.3390/bioengineering7030111
work_keys_str_mv AT guidoclara biomimeticnanocarriersforcancertargettherapy
AT maioranogabriele biomimeticnanocarriersforcancertargettherapy
AT cortesebarbara biomimeticnanocarriersforcancertargettherapy
AT damonestefania biomimeticnanocarriersforcancertargettherapy
AT palamailariaelena biomimeticnanocarriersforcancertargettherapy